Media Collections - Off-air Television Broadcasts (Part 1) - Library ...

Correspondent, Peter J. Boyer.
With adult movies and magazines, retail store sales and the growth of the
Internet, pornography is one of the hottest industries in America. This
investigative report examines the forces behind the recent explosion of sexually
explicit material available in American society and the pending political battle
that may engulf the multi-billion dollar pornography industry.
ERC VID.
338.47364 AMER.
DYING FOR DRUGS [VIDEORECORDING] / DIRECTORS, BRIAN WOODS, MICHAEL SIMKIN ;
PRODUCER, BRIAN WOODS.
Off-air recording of the SBS programme broadcast 05/04/05. Copied under Part 5A
of the Copyright Act 1968.
Colour recording system: PAL ; Region all.
Closed captioned for the hearing-impaired.
Copyright notice: Commonwealth of Australia. Copyright Regulations. 1969.
Warning.
Researcher, Deborah Shipley; editors, Reg Clarke, Jeremy Wales, Brian Edwards.
Reporter, Brian Woods.
This film investigates, firstly, into how drugs companies resort to expediency
to get their drugs approved quickly, side-stepping the Nuremberg codified rules
on human experimentations in medicine. Secondly, into how they use their
monopoly on supply to get the prices they want, earning billions. Footage of two
cases of unethical drugs testing on humans; and two cases of excessive pricing.
Case one involves Pfizer Inc.'s testing of a new meningitis drug on children in
1996, in Kano, Nigeria, far away from scrutiny. Case two involves Dr. Nancy
Olivieri and Apotex Inc. in their international trials with thalassemia major
patients, beginning in Toronto. Apotex curtails the study, determined to market
the new drug, L1, quickly; and fires trial chairperson, Dr. Olivieri, gagging
and intimidating her. In Korea, the overpricing of the leukemia drug, Glivec, by
Novartis places it beyond the reach of patients. While in Central America, the
excessive pricing of anti-retroviral medicines, by Pfizer, is forcing people to
illegally smuggle vastly cheaper generic drugs to try to save lives. Indian
drugs companies, like Cipla, make generic versions of drugs, selling them at a
fraction of the price charged by pharmaceutical giants. But, once the new W.T.O
agreement comes into effect, in 2006, India must provide full patent protection,
thereby threatening a generic drugs industry which supplies much of the world's
cheap drugs. With real competition gone, the powerful pharmaceutical industries
will be able to charge anything. The world could end up with a few big 'pharmas',
with the undesirable monolithic overuse of power to push pills, and life or
death. Interviews with international experts who analyse and appraise the cases
presented.
First released: [Australia : SBS-TV, c2005?] Original released in series: Hoc
docs.
DVD.
Report in English; dialogues in various languages with English subtitles.
ERC DVD.
338.47615 DYIN.
POWER TRIP [VIDEORECORDING] / DIRECTED, EDITED & PRODUCED BY PAUL DEVLIN.
Off-air recording of the SBS-TV program broadcast 24/2/04. Copied under Part 5A
of the Copyright Act 1968.
AES, the massive American global power company, has purchased Telasi, the ailing
electricity distribution company in Tbilisi, capital of the former Soviet
Republic of Georgia. Under Soviet communism, the government paid for electricity
or the cost was negligible. Local AES manager Piers Lewis must now train the
entire population that in the new market economy, customers have to pay for
their electricity. The Georgians meanwhile, from meter readers to the Energy
Minister, devise ever more clever ways to get it free.
Some English subtitles.